Ascom报告说,以142 100万瑞士法郎计的H1 2024净收入下降了2.7%,联合王国、法国/西班牙市场落后,而进货单减少了3个。 Ascom reported a 2.7% drop in H1 2024 net revenue at CHF 142.1M, with UK, France/Spain markets lagging, while incoming orders decreased 3.

Ascom报告,H1 2024年按固定货币计算的净收入下降2.7%,为142 100万瑞士法郎。 Ascom reported a 2.7% dip in net revenue at constant currencies for H1 2024, at CHF 142.1M. 关键市场达到了预期,但联合王国和法国/西班牙滞后。 Key markets met expectations, but UK & France/Spain lagged. 收到订单比2023年低3.1%,但比H2 2023高13%。 Incoming orders were 3.1% lower than 2023, but 13% higher than H2 2023. EBITDA的差值保持在7.4%。 EBITDA margin remained at 7.4%. 据阿斯科姆预计,在2024年,其净收入将保持稳定,EBITDA利率将达到9-10%. Ascom expects stable net revenue in 2024, with an EBITDA margin of 9-10%. 该公司计划在2024年和2025年通过新的平台加强其在保健和企业解决方案中的地位,并在2025年年中实现平台趋同。 The company plans to strengthen its position in healthcare and enterprise solutions through new platforms in 2024 & 2025, with platform convergence by mid-2025.